• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白伴侣 FACT 复合物介导氧化应激反应促进肝癌进展。

Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression.

机构信息

State Key Laboratory of Liver Research, University of Hong Kong, Hong Kong, Hong Kong.

Department of Pathology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong.

出版信息

Gut. 2020 Feb;69(2):329-342. doi: 10.1136/gutjnl-2019-318668. Epub 2019 Aug 22.

DOI:10.1136/gutjnl-2019-318668
PMID:31439637
Abstract

OBJECTIVE

Facilitates Chromatin Transcription (FACT) complex is a histone chaperone participating in DNA repair-related and transcription-related chromatin dynamics. In this study, we investigated its oncogenic functions, underlying mechanisms and therapeutic implications in human hepatocellular carcinoma (HCC).

DESIGN

We obtained HCC and its corresponding non-tumorous liver samples from 16 patients and identified FACT complex as the most upregulated histone chaperone by RNA-Seq. We further used CRISPR-based gene activation and knockout systems to demonstrate the functions of FACT complex in HCC growth and metastasis. Functional roles and mechanistic insights of FACT complex in oxidative stress response were investigated by ChIP assay, flow cytometry, gene expression assays and 4sU-DRB transcription elongation assay. Therapeutic effect of FACT complex inhibitor, Curaxin, was tested in both in vitro and in vivo models.

RESULTS

We showed that FACT complex was remarkably upregulated in HCC and contributed to HCC progression. Importantly, we unprecedentedly revealed an indispensable role of FACT complex in NRF2-driven oxidative stress response. Oxidative stress prevented NRF2 and FACT complex from KEAP1-mediated protein ubiquitination and degradation. Stabilised NRF2 and FACT complex form a positive feedback loop; NRF2 transcriptionally activates the FACT complex, while FACT complex promotes the transcription elongation of NRF2 and its downstream antioxidant genes through facilitating rapid nucleosome disassembly for the passage of RNA polymerase. Therapeutically, Curaxin effectively suppressed HCC growth and sensitised HCC cell to sorafenib.

CONCLUSION

In conclusion, our findings demonstrated that FACT complex is essential for the expeditious HCC oxidative stress response and is a potential therapeutic target for HCC treatment.

摘要

目的

有助于染色质转录的 FACT 复合物是一种参与 DNA 修复相关和转录相关染色质动力学的组蛋白伴侣。在本研究中,我们研究了其在人类肝细胞癌(HCC)中的致癌功能、潜在机制和治疗意义。

设计

我们从 16 名患者中获得 HCC 及其相应的非肿瘤性肝组织样本,并通过 RNA-Seq 鉴定 FACT 复合物为上调最明显的组蛋白伴侣。我们进一步使用基于 CRISPR 的基因激活和敲除系统来证明 FACT 复合物在 HCC 生长和转移中的作用。通过 ChIP 测定、流式细胞术、基因表达测定和 4sU-DRB 转录延伸测定研究了 FACT 复合物在氧化应激反应中的功能作用和机制见解。在体外和体内模型中测试了 FACT 复合物抑制剂 Curaxin 的治疗效果。

结果

我们表明 FACT 复合物在 HCC 中显著上调,并促进 HCC 进展。重要的是,我们以前所未有的方式揭示了 FACT 复合物在 NRF2 驱动的氧化应激反应中的不可或缺作用。氧化应激阻止了 NRF2 和 FACT 复合物与 KEAP1 介导的蛋白质泛素化和降解。稳定的 NRF2 和 FACT 复合物形成正反馈回路;NRF2 转录激活 FACT 复合物,而 FACT 复合物通过促进 RNA 聚合酶快速核小体解离来促进 NRF2 及其下游抗氧化基因的转录延伸。在治疗上,Curaxin 有效抑制 HCC 生长并增强 HCC 细胞对索拉非尼的敏感性。

结论

总之,我们的研究结果表明,FACT 复合物对于迅速的 HCC 氧化应激反应至关重要,是 HCC 治疗的潜在治疗靶点。

相似文献

1
Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression.组蛋白伴侣 FACT 复合物介导氧化应激反应促进肝癌进展。
Gut. 2020 Feb;69(2):329-342. doi: 10.1136/gutjnl-2019-318668. Epub 2019 Aug 22.
2
FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.FACT蛋白、SUPT16H和SSRP1是HIV-1和HTLV-1的转录抑制因子,可促进病毒潜伏。
J Biol Chem. 2015 Nov 6;290(45):27297-27310. doi: 10.1074/jbc.M115.652339. Epub 2015 Sep 16.
3
Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.靶向 FACT 的库尔沙因药物 CBL0137 有效抑制 MYC 扩增型 3 组髓母细胞瘤。
Cell Death Dis. 2020 Dec 2;11(12):1029. doi: 10.1038/s41419-020-03201-6.
4
Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.SLC46A3 的高表达可抑制肝细胞癌的进展及其对索拉非尼治疗的影响。
Biomed Pharmacother. 2019 Jun;114:108864. doi: 10.1016/j.biopha.2019.108864. Epub 2019 Apr 10.
5
Regulation of chromatin structure and function: insights into the histone chaperone FACT.染色质结构和功能的调控:组蛋白伴侣 FACT 的研究进展。
Cell Cycle. 2021 Mar-Mar;20(5-6):465-479. doi: 10.1080/15384101.2021.1881726. Epub 2021 Feb 16.
6
Epigenetic regulation of DNA repair gene program by Hippo/YAP1-TET1 axis mediates sorafenib resistance in HCC.Hippo/YAP1-TET1 轴通过表观遗传调控 DNA 修复基因程序介导 HCC 对索拉非尼的耐药性。
Cell Mol Life Sci. 2024 Jul 5;81(1):284. doi: 10.1007/s00018-024-05296-y.
7
Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.抗癌候选药物CBL0137可抑制组蛋白伴侣FACT,在替莫唑胺敏感和耐药的胶质母细胞瘤临床前原位模型中有效。
Neuro Oncol. 2017 Feb 1;19(2):186-196. doi: 10.1093/neuonc/now141.
8
The histone chaperone complex FACT promotes proliferative switch of G cancer cells.组蛋白伴侣复合物 FACT 促进 G 癌细胞的增殖转换。
Int J Cancer. 2019 Jul 1;145(1):164-178. doi: 10.1002/ijc.32065. Epub 2018 Dec 28.
9
Inhibition of the FACT Complex Targets Aberrant Hedgehog Signaling and Overcomes Resistance to Smoothened Antagonists.抑制 FACT 复合物靶向异常的 Hedgehog 信号转导并克服对 Smoothened 拮抗剂的耐药性。
Cancer Res. 2021 Jun 1;81(11):3105-3120. doi: 10.1158/0008-5472.CAN-20-3186. Epub 2021 Apr 14.
10
SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497.SSRP1促进肝细胞癌的恶性发展并受miR-497负调控。
Mol Ther. 2016 May;24(5):903-14. doi: 10.1038/mt.2016.9. Epub 2016 Jan 12.

引用本文的文献

1
A-to-I edited SNHG3 promotes non-small cell lung cancer metastasis by promoting fatty acid oxidation and resisting ferroptosis.A到I编辑的SNHG3通过促进脂肪酸氧化和抵抗铁死亡来促进非小细胞肺癌转移。
Commun Biol. 2025 Sep 2;8(1):1333. doi: 10.1038/s42003-025-08776-4.
2
The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics.肝细胞癌的表观遗传基础——生物标志物与治疗方法的机制及潜在方向
Br J Cancer. 2025 Jun;132(10):869-887. doi: 10.1038/s41416-025-02969-8. Epub 2025 Mar 8.
3
GLO1 regulates hepatocellular carcinoma proliferation and migration through the cell cycle pathway.
GLO1 通过细胞周期通路调控肝癌细胞的增殖和迁移。
BMC Cancer. 2024 Oct 21;24(1):1297. doi: 10.1186/s12885-024-12927-x.
4
Single-cell and spatial transcriptome assays reveal heterogeneity in gliomas through stress responses and pathway alterations.单细胞和空间转录组分析揭示了胶质瘤通过应激反应和通路改变的异质性。
Front Immunol. 2024 Aug 27;15:1452172. doi: 10.3389/fimmu.2024.1452172. eCollection 2024.
5
Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma.鉴定氧化应激基因在肝细胞癌中的预测作用及其相关药物。
Cancer Rep (Hoboken). 2024 Apr;7(4):e1978. doi: 10.1002/cnr2.1978.
6
Identification of ASF1A and HJURP by global H3-H4 histone chaperone analysis as a prognostic two-gene model in hepatocellular carcinoma.通过全局 H3-H4 组蛋白伴侣分析鉴定 ASF1A 和 HJURP 作为肝细胞癌的预后两基因模型。
Sci Rep. 2024 Apr 1;14(1):7666. doi: 10.1038/s41598-024-58368-1.
7
Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma.腺相关病毒(AAV)作为基因治疗剂在肝细胞癌中的最新进展。
Virol J. 2024 Jan 12;21(1):17. doi: 10.1186/s12985-024-02286-1.
8
Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma.七种与氧化应激相关的基因可预测肝细胞癌的预后。
Aging (Albany NY). 2023 Dec 14;15(24):15050-15063. doi: 10.18632/aging.205330.
9
The Preventive Mechanism of Anserine on Tert-Butyl Hydroperoxide-Induced Liver Injury in L-02 Cells via Regulating the Keap1-Nrf2 and JNK-Caspase-3 Signaling Pathways.鹅肌肽通过调控Keap1-Nrf2和JNK-Caspase-3信号通路对叔丁基过氧化氢诱导的L-02细胞肝损伤的预防机制
Mar Drugs. 2023 Aug 29;21(9):477. doi: 10.3390/md21090477.
10
Mechanism of sorafenib resistance associated with ferroptosis in HCC.肝癌中与铁死亡相关的索拉非尼耐药机制。
Front Pharmacol. 2023 Jun 7;14:1207496. doi: 10.3389/fphar.2023.1207496. eCollection 2023.